Non-Current Assets
PP&E (Net)
Moderna PP&E (Net) decreased by 2.2% to $2.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.7%, from $2.21B to $2.09B. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows an upward trend with a 48.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2017
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase indicates ongoing investment in physical capacity, whereas a decline may suggest aging assets or a strategy of asset-light operations.
Detailed definition
This metric represents the book value of tangible assets after subtracting accumulated depreciation from the total histo...
Peer comparison
Standard line item for all manufacturing and industrial companies; directly comparable across peers.
Metric ID:
property_plant_equipment_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $794.00M | $845.00M | $1.24B | $1.34B | $1.32B | $2.02B | $2.02B | $2.02B | $2.28B | $1.95B | $1.95B | $2.06B | $2.20B | $2.38B | $2.20B | $2.21B | $2.17B | $2.13B | $2.13B | $2.09B |
| QoQ Change | — | +6.4% | +46.9% | +8.1% | -1.3% | +52.5% | -0.0% | +0.0% | +13.0% | -14.4% | -0.4% | +6.1% | +6.4% | +8.4% | -7.8% | +0.7% | -1.9% | -2.0% | +0.4% | -2.2% |
| YoY Change | — | — | — | — | +66.8% | +138.9% | +62.6% | +50.5% | +72.2% | -3.3% | -3.6% | +2.2% | -3.7% | +22.0% | +12.9% | +7.2% | -1.2% | -10.7% | -2.8% | -5.7% |
Range$794.00M – $2.38B
CAGR+22.6%
Avg YoY Growth+25.3%
Median YoY Growth+4.7%
Geographic Breakdown — United States
| Segment | Q4 '24 |
|---|---|
| United States | $1.53B |
| Total | $2.20B |
Geographic Breakdown — Rest of world
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| Rest of world | $10.00M | $37.00M | $259.00M | $381.00M | $363.00M |
| Europe | $181.00M | $714.00M | $126.00M | $283.00M | $303.00M |
| Total | $1.24B | $2.02B | $1.95B | $2.20B | $2.13B |
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is Moderna's pp&e (net)?
- Moderna (MRNA) reported pp&e (net) of $2.09B in Q1 2026.
- How has Moderna's pp&e (net) changed year-over-year?
- Moderna's pp&e (net) decreased by 5.7% year-over-year, from $2.21B to $2.09B.
- What is the long-term trend for Moderna's pp&e (net)?
- Over 5 years (2020 to 2025), Moderna's pp&e (net) has grown at a 48.4% compound annual growth rate (CAGR), from $297.00M to $2.13B.
- What does pp&e (net) mean?
- The current book value of physical assets after accounting for wear and tear.